SKANSKA USA SELLS OFFICE, LAB BUILDING IN CAMBRIDGE FOR $94.5M
CAMBRIDGE, MASS. — Skanska USA has sold 150 Second Street, a 123,000-square-foot office and lab building in Cambridge, to Alexandria Real Estate Equities Inc. for $94.5 million. The three-story, Class A building is located in Kendall Square and features large windows and open floor plans. The building was 85 percent leased at the time of sale. Foundation Medicine Inc., a molecular information company that helps doctors identify targeted cancer treatments for patients, currently occupies 61,591 square feet. Bluebird Bio, a biotechnology company focused on helping patients with severe genetic and orphan diseases using gene therapy, will occupy 43,586 square feet beginning in January 2014.